Status: Recruiting
A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice
The main purpose of this study is to describe how well Guselkumab works after switching from Ustekinumab in participants with moderate to severe psoriasis in a routine clinical setting. A long-term skin disease that causes red, scaly and sometimes painful, itchy patches on the skin.
Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen-Cilag Kft.Updated: Aug 5, 2026Locations: 1
Eligibility criteria
Must have a confirmed diagnosis of moderate-to-severe plaque psoriasis requiring... [+3]
Contraindication or hypersensitivity to Guselkumab or any other ingredient in th... [+4]